SCHEMBL7547482

SCHEMBL7547482

COc1cccc(-c2cncc(-c3cn(CCN4CCCCC4)c4ccc(OC)cc34)c2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.55
FLT1 P17948 3/20 0.49
FLT4 P35916 3/20 0.49
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 3/20 0.45
GLA P06280 1/20 0.45
GAA P10253 1/20 0.45
HPGD P15428 1/20 0.45
RCE1 Q9Y256 1/20 0.45
HSD17B10 Q99714 1/20 0.43
HTR6 P50406 2/20 0.42
ESR1 P03372 1/20 0.42
BACE1 P56817 1/20 0.42
FLT3 P36888 1/20 0.41
HRH3 Q9Y5N1 2/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
CNR2 P34972 1/20 0.40
KMT2A Q03164 1/20 0.40
LTA4H P09960 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7558444 0.94 KDR (0.57) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7550504 0.93 KDR (0.59) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7550599 0.93 KDR (0.52) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7548695 0.93 KDR (0.52) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7554226 0.92 KDR (0.66) KDRFLT1FLT4BACE1FLT3
SCHEMBL7990446 0.91 KDR (0.56) KDRFLT1FLT4ALDH1A1HSD17B10
SCHEMBL7549155 0.91 KDR (0.56) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7504415 0.90 KDR (0.50) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7548026 0.88 KDR (0.60) KDRFLT1FLT4HTR6
SCHEMBL7554276 0.88 KDR (0.52) KDRFLT1FLT4KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed